Pharm

Misoprostol

search

Misoprostol, Cytotec, PGE1 Gel

  • Mechanism
  1. Misoprostol is a Prostaglandin E1 Analog
    1. Misoprostol is a pro-drug, that when taken orally is de-esterified to its active acid
  2. Effects
    1. Gastric Mucosa Protection by Prostaglandin replacement
    2. Cervical Ripening and uterine contractions
  • Indications
  • Medications
  1. Misoprostol (Cytotec)
  1. See NSAID Gastrointestinal Adverse Effects
  2. Option 1: 100 to 200 mcg four times daily with food
  3. Option 2: 200 mcg orally twice daily with food
    1. Better tolerated than four times per day dosing
  • Dosing
  • Obstetrics and Gynecology
  1. Cervical Ripening
    1. See Cervical Ripening for pregnancy dosing
    2. Misoprostol 50 mcg per vagina every 6 hours (or 25 mcg every 3 hours)
    3. Monitor for uterine hyperstimulation and Fetal Heart Rate
    4. Avoid after prior Cesarean Section, Multigravida (>=5 prior pregnancies)
      1. Risk of Uterine Rupture
  2. Early Pregnancy Loss (<84 days) or Termination of Pregnancy (<77 days)
    1. See Early Pregnancy Loss (includes precautions and monitoring protocol)
    2. Misoprostol Dosing Protocol
      1. Vaginal (or rectal)
        1. Place 800 mcg (4 tablets) intravaginally at 24-48 hours after Mifepristone
        2. Lie supine for 30 minutes after dose
      2. Buccal Dosing may be used in place of vaginal dosing
        1. Place two of the 200 mcg Misoprostol tablets on each side of the mouth (total 800 mcg)
        2. Allow tablets to dissolve over 30 minutes
      3. Efficacy improves if followed by second dose Misoprostol 800 mcg 4 hours after first
    3. Strong uterine cramping and heavier Vaginal Bleeding follows Misoprostol dose
      1. Onset within several hours
      2. Persists for 3-5 hours
      3. Lighter Vaginal Bleeding may persist for 9-16 days
    4. Adjunctive medications
      1. NSAIDs
      2. Heating pad
  • Safety
  1. Pregnancy Category X
  2. Avoid in Lactation
  • Adverse Effects
  1. When used orally (poorly tolerated)
    1. Diarrhea
    2. Nausea
    3. Vomiting
    4. Abdominal cramping
    5. Flatulence
  2. Gynecologic symptoms (800 mcg dosing)
    1. Strong uterine cramping
    2. Vaginal Bleeding heavier than typical Menses
  1. Dosing qid: 4% Peptic Ulcer Disease recurrence
  2. Dosing bid: 8% Peptic Ulcer Disease recurrence
  3. Placebo: 16% Peptic Ulcer Disease recurrence
  4. Reference
    1. Raskin (1995) Ann Intern Med 123:344-50 [PubMed]